🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congrats to our partner Lorenzo Degli Esposti, who won the Special Prize Elena Benaduce 🏅by GiovediScienza for #scicomm! Very proud of you to bring on the legacy of CUPIDO and #nanomedicine 🙌🎉

Another awesome result for one of our partners! Eride Quarta from PlumeStars got awarded the EUFEPS Women In Pharmaceutical Sciences Awards 2021 with her talk on inhalable microparticles developed within CUPIDO. Well deserved 👏👩‍🔬 #nanomedicine #WomenInSTEM

#Research Topic The Role of Circulating Immune Mediators in the Crosstalk Between Cells of the Immune System and Cardiovascular Systems in CVDs ⁦Frontiers - Immunology⁩ frontiersin.org/research-topic…

Nano- and Micro-carrier Based #Cardiovascular Drug Delivery. A new Research Topic Frontiers in Drugs Portfolio has been lunched frontiersin.org/research-topic… #DrugDelivery, #DrugDiscovery, #nano #micro #DrugSafety

The Sheikh lab is recruiting postdocs to sunny #SanDiego with interest in molecular cardiology! Explore new methods to define therapeutic targets for cardiomyopathy--with focus on translation to industry! DM me! Please RT. #postdocjobs #phdjobs #academia #UCSD interested?MrBeast

Nano-miR-133a Replacement #Therapy Blunts Pressure Overload–Induced #HeartFailure #DrugDelivery #cardio #ncRNA #microRNA #inhalation CUPIDO European Commission ahajournals.org/doi/10.1161/CI…

#ResearchLetter MicroRNA therapeutics in cardiology is limited by invasive administration. Daniele Catalucci et al. demonstrate a proof-of-concept inhalable nanoparticle microRNA delivery mechanism CNR Consiglio Nazionale delle Ricerche Humanitas Milano ahajournals.org/doi/10.1161/CI…

A #research_position is #available for either a junior or post-doctoral fellow. #Nanotherapeutic approaches for #COVID19 and #HeartFailure #Milan #job #research #fellowship humanitas-research.org/groups/daniele… irgb.cnr.it/people-4-3-2/d…

at the TecMedLab Università di Parma in collaboration with CNR Consiglio Nazionale delle Ricerche and Humanitas Milano we growth SiC semiconductive nanowires to reinstate impulse propagation in 5 hrs after myocardial infarction. See our work published on Nature Communications. rdcu.be/cEGsL

National Research Council (CNR) Institute of Genetic and Biomedical Research (IRGB) is #hiring a Research Position (either a junior or post- doctoral fellow)! #openposition jobs.escardio.org/research-posit…

Sofinnova Partners Announces New Investment In Nanophoria, Developer Of An Innovative Non-viral Drug Delivery Platfo crweworld.com/article/news-p…

We are pleased to welcome NanoPhoria to our portfolio via a €3.5 million seed investment that will advance its pre-clinical stage treatment for heart failure. #biotech hubs.ly/Q01bb_ms0

In its eighth disclosed investment from its Italy-focused Telethon fund, Sofinnova Partners has backed non-viral delivery company NanoPhoria with a €3.5M seed investment buff.ly/3PdKeiZ

La startup biotech NanoPhoria incassa un round 3,5 milioni dlvr.it/SQRy3M

NanoPhoria, società spin-off del #Cnr, ha ricevuto un investimento di 3,5milioni € da parte di Sofinnova Partners, una delle principali società europee di venture capital nel settore delle scienze della vita. La società sarà presentata oggi a #Bioequity Milano cnr.it/it/news/11112

Discovering #NanoPhoria, a cutting-edge and brand-new startup developing a revolutionary and promising #HeartFailure inhalation treatment. Claudio De Luca, our CEO, explains how. Spoiler alert: it's done by a non-viral, biomimetic nanocarrier technology. linkedin.com/posts/nanophor…

Dry powder inhalation technology for heart targeting applied to calcium phosphate nanoparticles loaded with active substances genscript.com/index.php/refe… GenScript

Prosegue la sperimentazione dell'innovativa formulazione inalatoria per il trattamento delle malattie cardiache messa a punto nell’ambito del CUPIDO. I risultati sono descritti da uno studio coordinato da #Cnr_Irgb e Charité - Universitätsmedizin Berlin 👇 cnr.it/it/nota-stampa… MariaChiara Carrozza

DZHK Paper of the Month | Feb 2024 🥁🏆 From the 🫁 to the 🫀: Read about a novel peptide-based inhalation therapeutic for the treatment of #HeartFailure Congratulations to Alessio Alogna Deutsches Herzzentrum der Charité & his team tinyurl.com/yws8zue3 #CardioTwitter

A research position is available within a funded PRIN 2022 PNRR project entitled “A Chaperone Network Shapes Heart Resilience During Stress and Aging.” Join us to investigate the molecular mechanisms underlying chaperone protection in cardiac aging. jobrxiv.org/job/national-r…